
Keywords: biomarkers; diabetes; review; tuberculosis; AGE; advanced glycation end product; DM; diabetes mellitus; IFN; interferon; LTBI; latent tuberculosis infection; NR; nuclear receptor; PPAR; peroxisome proliferator-activated receptor; RAGE; receptor for advanc